FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014487511> ?p ?o ?g. }

• W3014487511 endingPage "e0226661" @default.
• W3014487511 startingPage "e0226661" @default.
• W3014487511 abstract "CD47 is an immune checkpoint protein that downregulates both the innate and adaptive anti-tumor immune response via its counter receptor SIRPα. Biologics, including humanized CD47 monoclonal antibodies and decoy SIRPα receptors, that block the SIRPα-CD47 interaction, are currently being developed as cancer immunotherapy agents. However, adverse side effects and limited penetration of tumor tissue associated with their structure and large size may impede their clinical application. We recently developed a quantitative high throughput screening assay platform to identify small molecules that disrupt the binding of SIRPα and CD47 as an alternative approach to these protein-based therapeutics. Here, we report on the development and optimization of a cell-based binding assay to validate active small molecules from our biochemical screening effort. This assay has a low volume, high capacity homogenous format that relies on laser scanning cytometry (LSC) and associated techniques to enhance signal to noise measurement of cell surface binding. The LSC assay is specific, concentration dependent, and validated for the two major human SIRPα variants (V1 and V2), with results that parallel those of our biochemical data as well as published studies. We also utilized the LSC assay to confirm published studies showing that the inhibition of amino-terminal pyroglutamate formation on CD47 using the glutaminyl cyclase inhibitor SEN177 disrupts SIRPα binding. The SIRPα-CD47 interaction could be quantitatively measured in live and fixed tumor cells. Use of fixed cells reduces the burden of cell maintenance and provides stable cell standards to control for inter- and intra-assay variations. We also demonstrate the utility of the assay to characterize the activity of the first reported small molecule antagonists of the SIRPα-CD47 interaction. This assay will support the screening of thousands of compounds to identify or validate active small molecules as hits, develop structure activity relationships and assist in the optimization of hits to leads by a typical iterative medicinal chemistry campaign." @default.
• W3014487511 created "2020-04-10" @default.
• W3014487511 creator A5002880395 @default.
• W3014487511 creator A5008374321 @default.
• W3014487511 creator A5009704468 @default.
• W3014487511 creator A5010552508 @default.
• W3014487511 creator A5014278257 @default.
• W3014487511 creator A5031078822 @default.
• W3014487511 creator A5045375697 @default.
• W3014487511 creator A5047037926 @default.
• W3014487511 creator A5053364502 @default.
• W3014487511 creator A5091208881 @default.
• W3014487511 date "2020-04-02" @default.
• W3014487511 modified "2023-09-29" @default.
• W3014487511 title "A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncology" @default.
• W3014487511 cites W1595098530 @default.
• W3014487511 cites W1598843567 @default.
• W3014487511 cites W1925857700 @default.
• W3014487511 cites W1957657505 @default.
• W3014487511 cites W1975327241 @default.
• W3014487511 cites W1997065981 @default.
• W3014487511 cites W2006959956 @default.
• W3014487511 cites W2035126650 @default.
• W3014487511 cites W2036013134 @default.
• W3014487511 cites W2039949492 @default.
• W3014487511 cites W2043249881 @default.
• W3014487511 cites W2057139597 @default.
• W3014487511 cites W2057774884 @default.
• W3014487511 cites W2070268146 @default.
• W3014487511 cites W2073673847 @default.
• W3014487511 cites W2074339161 @default.
• W3014487511 cites W2091133773 @default.
• W3014487511 cites W2097995306 @default.
• W3014487511 cites W2100460498 @default.
• W3014487511 cites W2103746815 @default.
• W3014487511 cites W2104849855 @default.
• W3014487511 cites W2106496177 @default.
• W3014487511 cites W2123363005 @default.
• W3014487511 cites W2133346943 @default.
• W3014487511 cites W2139418176 @default.
• W3014487511 cites W2141253335 @default.
• W3014487511 cites W2143772132 @default.
• W3014487511 cites W2170756973 @default.
• W3014487511 cites W2205886515 @default.
• W3014487511 cites W2339658610 @default.
• W3014487511 cites W2341432578 @default.
• W3014487511 cites W2468576628 @default.
• W3014487511 cites W2529484692 @default.
• W3014487511 cites W2587691649 @default.
• W3014487511 cites W2590534615 @default.
• W3014487511 cites W2596636194 @default.
• W3014487511 cites W2612383893 @default.
• W3014487511 cites W2795318100 @default.
• W3014487511 cites W2807568660 @default.
• W3014487511 cites W2882970743 @default.
• W3014487511 cites W2888262269 @default.
• W3014487511 cites W2899044337 @default.
• W3014487511 cites W2918786033 @default.
• W3014487511 cites W2954587554 @default.
• W3014487511 cites W2980779572 @default.
• W3014487511 cites W4237810504 @default.
• W3014487511 doi "https://doi.org/10.1371/journal.pone.0226661" @default.
• W3014487511 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7117682" @default.
• W3014487511 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32240171" @default.
• W3014487511 hasPublicationYear "2020" @default.
• W3014487511 type Work @default.
• W3014487511 sameAs 3014487511 @default.
• W3014487511 citedByCount "15" @default.
• W3014487511 countsByYear W30144875112020 @default.
• W3014487511 countsByYear W30144875112021 @default.
• W3014487511 countsByYear W30144875112022 @default.
• W3014487511 countsByYear W30144875112023 @default.
• W3014487511 crossrefType "journal-article" @default.
• W3014487511 hasAuthorship W3014487511A5002880395 @default.
• W3014487511 hasAuthorship W3014487511A5008374321 @default.
• W3014487511 hasAuthorship W3014487511A5009704468 @default.
• W3014487511 hasAuthorship W3014487511A5010552508 @default.
• W3014487511 hasAuthorship W3014487511A5014278257 @default.
• W3014487511 hasAuthorship W3014487511A5031078822 @default.
• W3014487511 hasAuthorship W3014487511A5045375697 @default.
• W3014487511 hasAuthorship W3014487511A5047037926 @default.
• W3014487511 hasAuthorship W3014487511A5053364502 @default.
• W3014487511 hasAuthorship W3014487511A5091208881 @default.
• W3014487511 hasBestOaLocation W30144875111 @default.
• W3014487511 hasConcept C161624437 @default.
• W3014487511 hasConcept C170493617 @default.
• W3014487511 hasConcept C185592680 @default.
• W3014487511 hasConcept C203014093 @default.
• W3014487511 hasConcept C2777701055 @default.
• W3014487511 hasConcept C2780104668 @default.
• W3014487511 hasConcept C2780674031 @default.
• W3014487511 hasConcept C2780851360 @default.
• W3014487511 hasConcept C502942594 @default.
• W3014487511 hasConcept C55493867 @default.
• W3014487511 hasConcept C85196483 @default.
• W3014487511 hasConcept C86803240 @default.
• W3014487511 hasConcept C8891405 @default.
• W3014487511 hasConceptScore W3014487511C161624437 @default.

• next